Human Urinary Composition Controls Siderocalin's Antibacterial Activity.

Shields-Cutler, Robin R; Crowley, Jan R; Hung, Chia S; Stapleton, Ann E; Aldrich, Courtney C; Marschall, Jonas; Henderson, Jeffrey P (2015). Human Urinary Composition Controls Siderocalin's Antibacterial Activity. Journal of biological chemistry, 290(26), pp. 15949-15960. American Society for Biochemistry and Molecular Biology 10.1074/jbc.M115.645812

Text jbc.M115.645812.full.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (5MB)

During Escherichia coli urinary tract infections, cells in the human urinary tract release the antimicrobial protein siderocalin (SCN; also known as lipocalin 2, neutrophil gelatinase-associated lipocalin/NGAL, or 24p3). SCN can interfere with E. coli iron acquisition by sequestering ferric iron complexes with enterobactin, the conserved E. coli siderophore. Here we find that human urinary constituents can reverse this relationship, instead making enterobactin critical for overcoming SCN-mediated growth restriction. Urinary control of SCN activity exhibits wide ranging individual differences. We used these differences to identify elevated urinary pH and aryl metabolites as key biochemical host factors controlling urinary SCN activity. These aryl metabolites are well-known products of intestinal microbial metabolism. Together, these results identify an innate antibacterial immune interaction that is critically dependent upon individualistic chemical features of human urine.

Interest & Impact

Downloads

2 since deposited on 29 May 2015
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item